The briefing
Researchers at Fox Chase Cancer Center report that inhibiting the ANO6 protein in preclinical models slows pancreatic tumor growth and reduces immune suppression. The findings suggest ANO6 as a potential therapeutic target warranting further study.
Original headline
Targeting ANO6 protein weakens pancreatic cancer and boosts immunity